4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-063644
Chief Dev. & Ops. Officer bought 300 shares at $16.54 ($4,962)
From the SEC's structured data for this filing
Trades in this filing
Shemesh Shay · Chief Dev. & Ops. Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-05-20 | Purchase : show line 1 in the form | +300 | $16.54 | $4,962 | 1,241,435 | D |
| Open-market purchases · 300 sh · avg $16.54 · $4,962 | ||||||
Loading xslF345X03/tm2216562-1_4seq1.xml…